Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$21.2M Buy
58,570
+598
+1% +$205K 1.46% 29
2026
Q1
$20.4M Buy
57,972
+20,015
+53% +$7.14M 1.51% 29
2025
Q4
$12.4M Buy
37,957
+1,293
+4% +$410K 0.85% 45
2025
Q3
$10.3M Sell
36,664
-203
-0.6% -$58.9K 0.71% 47
2025
Q2
$10.3M Buy
36,867
+1,748
+5% +$495K 1.01% 39
2025
Q1
$10.9M Buy
35,119
+5,282
+18% +$1.56M 1.18% 34
2024
Q4
$7.78M Buy
29,837
+409
+1% +$121K 0.85% 39
2024
Q3
$9.48M Buy
29,428
+1,229
+4% +$402K 1.03% 39
2024
Q2
$8.81M Sell
28,199
-2,013
-7% -$591K 1.11% 37
2024
Q1
$8.59M Buy
30,212
+224
+0.7% +$65.5K 0.96% 39
2023
Q4
$8.64M Buy
29,988
+350
+1% +$95.4K 1.05% 38
2023
Q3
$7.97M Buy
29,638
+382
+1% +$95.3K 1.02% 39
2023
Q2
$6.5M Sell
29,256
-89
-0.3% -$20.7K 0.79% 44
2023
Q1
$7.09M Sell
29,345
-461
-2% -$113K 0.88% 43
2022
Q4
$7.83M Buy
29,806
+293
+1% +$78.5K 0.92% 41
2022
Q3
$6.65M Buy
29,513
+170
+0.6% +$41.2K 0.88% 45
2022
Q2
$7.14M Buy
29,343
+1,553
+6% +$381K 0.86% 45
2022
Q1
$6.72M Buy
27,790
+229
+0.8% +$52.6K 0.69% 50
2021
Q4
$6.2M Buy
27,561
+565
+2% +$119K 0.63% 53
2021
Q3
$5.74M Sell
26,996
-22,946
-46% -$5.28M 0.63% 54
2021
Q2
$12.2M Buy
49,942
+1,471
+3% +$362K 1.32% 34
2021
Q1
$12.1M Buy
48,471
+1,025
+2% +$245K 1.37% 31
2020
Q4
$10.9M Buy
47,446
+704
+2% +$162K 1.3% 36
2020
Q3
$11.9M Buy
46,742
+597
+1% +$148K 1.59% 26
2020
Q2
$10.9M Buy
46,145
+2,483
+6% +$567K 1.54% 28
2020
Q1
$8.85M Buy
43,662
+1,399
+3% +$306K 1.56% 24
2019
Q4
$10.2M Buy
42,263
+443
+1% +$97.7K 1.28% 30
2019
Q3
$8.09M Buy
41,820
+4,810
+13% +$923K 1.08% 37
2019
Q2
$6.82M Buy
37,010
+3,674
+11% +$658K 0.98% 39
2019
Q1
$6.33M Buy
33,336
+4,442
+15% +$848K 0.97% 36
2018
Q4
$5.63M Buy
28,894
+15,944
+123% +$3.11M 0.99% 38
2018
Q3
$2.68M Buy
12,950
+2,252
+21% +$444K 0.44% 51
2018
Q2
$1.98M Buy
10,698
+409
+4% +$72.3K 0.35% 53
2018
Q1
$1.75M Buy
10,289
+367
+4% +$67.4K 0.34% 52
2017
Q4
$1.73M Buy
9,922
+112
+1% +$19.8K 0.31% 57
2017
Q3
$1.83M Sell
9,810
-447
-4% -$79.2K 0.35% 57
2017
Q2
$1.77M Buy
10,257
+25
+0.2% +$4.07K 0.35% 56
2017
Q1
$1.68M Buy
+10,232
New +$1.7M 0.34% 58
2016
Q4
Sell
-908
Closed -$151K 99
2016
Q3
$151K Sell
908
-67
-7% -$11.3K 0.04% 94
2016
Q2
$148K Hold
975
0.04% 98
2016
Q1
$146K Hold
975
0.04% 91
2015
Q4
$158K Sell
975
-25
-3% -$3.93K 0.04% 88
2015
Q3
$138K Hold
1,000
0.03% 84
2015
Q2
$154K Hold
1,000
0.04% 83
2015
Q1
$160K Buy
+1,000
New +$157K 0.04% 85
2014
Q4
Sell
-1,000
Closed -$140K 97
2014
Q3
$140K Hold
1,000
0.03% 94
2014
Q2
$118K Hold
1,000
0.03% 103
2014
Q1
$123K Hold
1,000
0.03% 94
2013
Q4
$114K Sell
1,000
-30
-3% -$3.41K 0.03% 105
2013
Q3
$115K Hold
1,030
0.03% 106
2013
Q2
$102K Buy
+1,030
New +$107K 0.03% 114

Other funds holding AMGN

CapWealth Advisors's AMGN Position: Q2 2026 in Review

CapWealth Advisors increased its Amgen (AMGN) stake by 1% in Q2 2026, buying an estimated $205K and bringing the position to 58,570 shares worth $21.2M. The position accounts for 1.46% of the portfolio, ranked #29.

CapWealth Advisors first reported a position in AMGN in Q2 2013 and has held it in 51 quarters since. 1,543 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • CapWealth Advisors held 58,570 shares of Amgen worth $21.2M as of Q2 2026.
  • CapWealth Advisors bought 598 Amgen shares in Q2 2026, an estimated $205K.
  • Amgen made up 1.46% of CapWealth Advisors's portfolio in Q2 2026, its #29 holding.
  • CapWealth Advisors first reported a position in Amgen in Q2 2013 and has held it in 51 quarters since.
  • 1,543 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on CapWealth Advisors's 13F filing for Q2 2026, filed 28 Jul 2026.